NEW YORK (GenomeWeb News) – Idaho Technology today said that it has licensed to Finnzymes intellectual property covering reagents or methods using SYBR Green I technology and melting curve analysis for real-time PCR applications.

Salt Lake City-based Idaho Technology said that the agreement became effective on April 3. Further terms were not disclosed.

The firm noted that it licenses its IP in cooperation with Roche Diagnostics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.